Bioqual (BIOQ) Hisse Fiyat
Bioqual Fiyat
Gelir, son 22 yılda yıllık bileşik %4,1 artarak 39,95 M USD seviyesine ulaştı. Hisse başına kâr, son 20 yılda yıllık %1,7 geriledi. Bioqual şirketinde net marj %-10,4 seviyesinde bulunuyor; birkaç yıl önceki %8,0 seviyesine göre geriledi. Bioqual şu anda yaklaşık %1,52 temettü verimi sunuyor. Temettü dağıtım oranı, kârın yaklaşık %54 düzeyindedir. Temettü, son 19 yılda yıllık %8,3 artış gösterdi.
Bioqual hisse senedi fiyatı
Bioqual iş modeli ve hisse analizi
Bioqual hakkında sık sorulan sorular
The business model of Bioqual Inc is to provide contract research services to biotechnology and pharmaceutical companies, government agencies, and academic institutions. Bioqual specializes in preclinical and clinical research, including animal model development, in vitro testing, and regulatory compliance. Through collaboration with clients, Bioqual aims to advance the development of drugs, vaccines, and therapeutics, ultimately contributing to the improvement of human and animal health. With its expertise and state-of-the-art facilities, Bioqual Inc has established itself as a trusted partner in the biomedical research industry.
Bioqual Inc is primarily active in the pharmaceutical and biotechnology industries.
The main competitors of Bioqual Inc in the market include Company A, Company B, and Company C. These companies operate in the same industry and offer similar products and services to Bioqual Inc. Their competitive presence challenges Bioqual Inc's market position and drives innovation within the industry. Maintaining a competitive edge is crucial for Bioqual Inc to attract and retain customers, expand its market share, and achieve long-term success. As Bioqual Inc continues to navigate its way in the market, it recognizes the importance of monitoring and adapting to the strategies and offerings of its key competitors.
Bioqual Inc. is a reputable company with a rich history and background. Established in [year], Bioqual Inc. has been a leading player in the [industry] sector. The company specializes in [specific products/services] and has built a strong reputation for its commitment to innovation, quality, and customer satisfaction. With a team of experienced professionals and state-of-the-art facilities, Bioqual Inc. has consistently delivered outstanding results and garnered recognition for its contributions to [industry]. Over the years, Bioqual Inc. has expanded its presence globally and continues to be a trusted name in the [industry] market, providing sustainable solutions and driving advancements in [industry].
Bioqual Inc has achieved several significant milestones over the years. The company has successfully gained recognition as a leading biomedical research organization, specializing in preclinical and clinical testing services. Notably, Bioqual Inc has garnered a strong reputation for its contributions to drug development, infectious disease research, and vaccine testing. The company has also established numerous strategic partnerships with pharmaceutical and biotech companies, academia, and government agencies. Furthermore, Bioqual Inc has consistently demonstrated exceptional scientific expertise, state-of-the-art facilities, and a commitment to quality, making it a trusted name in the industry.
Bioqual Inc is primarily present in the United States.
Bioqual Inc represents a commitment to excellence in the field of biomedical research. With a strong emphasis on animal modeling and preclinical testing services, Bioqual is dedicated to paving the way for breakthrough discoveries in healthcare and life sciences. The company's corporate philosophy revolves around comprehensive expertise, innovative solutions, and ensuring the highest standards of animal welfare. By providing state-of-the-art facilities and a team of skilled professionals, Bioqual strives to support scientific advancements and contribute to the development of novel therapies and vaccines. With a focus on quality, reliability, and integrity, Bioqual Inc is trusted by leading pharmaceutical and biotechnology companies worldwide.
Güncel döviz kuruyla Bioqual hissesi 29,45 EUR (33,00 USD) seviyesindedir.
Bioqual Inc is a US-based company specializing in providing research services and products for the life sciences, pharmaceuticals, and biotechnology industries. The company was founded in 1981 and has been offering innovative solutions to its customers since then.
'nin Bioqual hasılatı 39,95 M USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
'nin Bioqual karı -4,17 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Bioqual'nin Fiyat/Kazanç (F/K) oranı şu anda -7,08'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Bioqual hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Bioqual'nin Fiyat/Satış (F/S) oranı şu anda 0,74'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Bioqual hisse senedinin değerleme metriği olarak hizmet eder.
Bioqual'nin Eulerpool Kalite Puanı 1/10'dur.
Bioqual'nin ISIN'i US09065J1016'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Bioqual'nin ticker'ı BIOQ'dir. Ticker sembolü, Bioqual hisseleri borsada işlem görmek için kullanılır.
Bioqual Hissesi
Bioqual Emsaller Grubu
Bioqual FIGI
Bioqual'nin tüm temel göstergeleri ve derinlemesine analizi
Bioqual hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Bioqual şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: